Urological cancer: Is docetaxel the 'black widow' of mCRPC drugs?
Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Bobby C
BC
Liaw
Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
William K
WK
Oh
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000008:administration & dosage*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*; D013792:Thalidomide / Q000031:analogs & derivatives*
D043823:Taxoids; D013792:Thalidomide; D011241:Prednisone